ENDODIAGNOSIS
Access EndoSure - tier 1 testing for endometriosisDiagnosis for endometriosis in a single clinic visit.
- Painless, Fast & 99% accurate1
- Detects all stages & types of disease
- Appropriate for all ages from pre-teens to post-menopausal
How does it Work?
In under an hour, ENDOSURE test results support your clinician’s decisions
Fighting for Faster Diagnosis
Despite growing awareness of the condition, many women wait years to be diagnosed with endometriosis. We’ve changed that.
After Diagnosis - What's next?
Diagnosis expedites the path to treatment, symptom management and stopping future disease progression.
Closing the diagnositic gap
The Endometriosis diagnosis dilemma
Endometriosis is an estrogen-dependent, frequently chronic inflammatory disease associated with pelvic and abdominal pain, bloating, painful irregular bowel or urinary symptoms, and/or infertility.
Symptomatic endometriosis has an estimated population prevalence of at least 10% globally, with most experiencing significant diagnostic delays of 3 to 11 years from onset of symptoms.3 Data of at-risk populations shows that 45% of adolescents and 55% of early adults have underlying endometriosis as the cause for regular dysmenorrhea.
Until now, TIER-1 rapid diagnostic testing that supported timely diagnosis and treatment was unavailable.
Diagnostic delays
Limitations in current diagnostic tests to detect early stage disease created the need for laparoscopy, the current gold standard for diagnosis, contributing to a 5-10+ year diagnostic delay between onset of symptoms and diagnosis of endometriosis.
It was never in your head. It was in your gut.
With symptoms overlapping with other conditions, pain viewed as normal by the patient &/or their treating clinician, and a lack of Tier-1 testing, patients suffered for years without answers.
Now we can test for it.
ENDOSURE detects endometriosis presence with 99% accuracy. Tier-1 ENDOSURE test provides clinicians with decision support so they can rapidly confirm endometriosis as the cause of menstrual pain, abdominal pain and infertility. This helps women receive care much earlier and may be the best hour they’ve ever invested in their health.
ENDOSURE, the only Tier 1 test for endometriosis
Mechanism of Action
Endometriosis causes unusual contractile patterns in the small bowel due to higher than normal serum levels of prostaglandins secreted by endometriosis tissues, despite disease location; peritoneal, ovarian, extra pelvic or intrauterine. While normal ranges of gut contractions are 1-12 cycles per minute (CPM) in healthy women, prostaglandins cause uncontrolled high-frequency contractions ranging from 15-200 CPM when endometriosis is present. This causes many of the painful symptoms associated with endometriosis.
During ENDOSURE testing, an electroviscerography system (EVG) objectively collects your gastrointestinal myoelectric activity (GIMA) data, then compares your GIMA to the “GIMA biomarker for endometriosis” to detect disease presence. In clinical studies, the test has 99% accuracy for those less than 36 years old and 98% accuracy for patients 36 yrs +. These finding were surgically verification, reflecting a strong ability to distinguish between positive and negative cases.1
ENDOSURE test results offer clinical decision support, when endometriosis is suspected. With testing more like an ECG, Tier 1 diagnostic testing for endometriosis is now fast, easy, safe and accurate.
Endosure test
Patient testimonials
Blogs
Optimal Timing for Endometriosis Testing
Endometriosis is a common gynecologic condition linked to pelvic pain and reduced fertility. Determining when to test helps enable earlier diagnosis and appropriate management. This article summarizes clinical indicators for testing, the role of the ENDOSURE test in...
Edmonton Women’s Health Event Tackles Endometriosis Diagnosis
Edmonton, Alberta – Edmontonians are being invited to take part in the community led Women's Health Symposium taking place on April 25, 2026 at the Holiday Inn Conference Centre in South Edmonton, offering discussion and education on the recent elimination of the...
Facing Unexplained Infertility? Know the Signs of Endometriosis & how to access rapid Endometriosis Diagnosis
A two-third majority of infertile women exhibit endometriosis. The prevalence of endometriosis in infertile women was higher than expected.
Research
- Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. J Clin Med. 2024;13(10):2866. Published 2024 May 13. doi:10.3390/jcm13102866
- Singh, S., et al; Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30000 Women, Journal of Obstetrics and Gynaecology Canada, Volume 42, Issue 7, 829 – 838
- World Health Organization. Endometriosis. Published March 24, 2023. Accessed November 25, 2024. https://www.who.int/news-room/fact-sheets/detail/endometriosis
- Nnoaham, Kelechi E. et al., Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries, Fertility and Sterility, Volume 96, Issue 2, 366 – 373.e8
Don’t see a clinic near you?
We’ll let you know when new clinics open.
